https://www.ecri-trials.com/about-ecri/ 0.5 daily 2025-09-24 https://www.ecri-trials.com/about-ecri/ecri-events/ 0.5 daily 2022-02-11 https://www.ecri-trials.com/about-ecri/ecri-news/ 0.5 daily 2025-09-24 https://www.ecri-trials.com/contact/ 0.5 daily 2014-10-27 https://www.ecri-trials.com/directions/ 0.5 daily 2014-10-27 https://www.ecri-trials.com/disclaimer/ 0.5 daily 2021-02-03 https://www.ecri-trials.com/faculty/ 0.5 daily 2025-09-21 https://www.ecri-trials.com/faculty/adrian-banning/ 0.5 daily 2014-10-27 https://www.ecri-trials.com/faculty/david-kandzari/ 0.5 daily 2022-10-03 https://www.ecri-trials.com/faculty/jan-tijssen/ 0.5 daily 2021-03-13 https://www.ecri-trials.com/faculty/joost-daemen/ 0.5 daily 2021-05-06 https://www.ecri-trials.com/faculty/jose-maria-de-la-torre-hernandez/ 0.5 daily 2022-10-23 https://www.ecri-trials.com/faculty/juan-f-iglesias/ 0.5 daily 2023-11-10 https://www.ecri-trials.com/faculty/luca-testa/ 0.5 daily 2022-06-14 https://www.ecri-trials.com/faculty/philippe-pibarot/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/faculty/victoria-delgado/ 0.5 daily 2022-10-23 https://www.ecri-trials.com/ 0.5 daily 2025-07-29 https://www.ecri-trials.com/log-out/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/network/ 0.5 daily 2021-01-26 https://www.ecri-trials.com/organisation/ 0.5 daily 2021-02-14 https://www.ecri-trials.com/organisation/board/ 0.5 daily 2021-03-11 https://www.ecri-trials.com/organisation/publication-policy/ 0.5 daily 2025-04-22 https://www.ecri-trials.com/organisation/the-role-of-ecri/ 0.5 daily 2021-02-14 https://www.ecri-trials.com/page-after-login/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/studies/ 0.5 daily 2014-10-27 https://www.ecri-trials.com/studies/absorb-stemi/ 0.5 daily 2021-03-13 https://www.ecri-trials.com/studies/absorb-stemi/patient-enrolment/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/fast-iii/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/studies/fast-iii/contact/ 0.5 daily 2021-07-03 https://www.ecri-trials.com/studies/fast-iii/news/ 0.5 daily 2021-08-09 https://www.ecri-trials.com/studies/fast-iii/partners/ 0.5 daily 2021-09-02 https://www.ecri-trials.com/studies/fast-iii/study-design/ 0.5 daily 2021-07-03 https://www.ecri-trials.com/studies/fast-iii/study-purpose/ 0.5 daily 2021-07-03 https://www.ecri-trials.com/studies/galileo-4d/ 0.5 daily 2016-05-13 https://www.ecri-trials.com/studies/galileo-4d/contact/ 0.5 daily 2021-02-04 https://www.ecri-trials.com/studies/galileo-4d/partners/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/studies/galileo-4d/patient-enrolment/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/galileo-4d/steering-committee/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/galileo-4d/study-design/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/studies/galileo-4d/study-news/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/studies/galileo-4d/study-purpose/ 0.5 daily 2016-05-12 https://www.ecri-trials.com/studies/global-leaders/ 0.5 daily 2021-03-13 https://www.ecri-trials.com/studies/global-leaders/patient-enrolment/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/ivus-chip/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/ivus-chip/contact/ 0.5 daily 2021-07-03 https://www.ecri-trials.com/studies/ivus-chip/partners/ 0.5 daily 2021-09-02 https://www.ecri-trials.com/studies/ivus-chip/patient-enrolment/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/studies/ivus-chip/study-design/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/ivus-chip/study-news/ 0.5 daily 2021-09-02 https://www.ecri-trials.com/studies/ivus-chip/study-purpose/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/ivus-chip-upp-registry/ 0.5 daily 2025-07-29 https://www.ecri-trials.com/studies/master-dapt/ 0.5 daily 2025-05-24 https://www.ecri-trials.com/studies/master-dapt/contact/ 0.5 daily 2021-02-03 https://www.ecri-trials.com/studies/master-dapt/partners/ 0.5 daily 2017-01-12 https://www.ecri-trials.com/studies/master-dapt/patient-enrolment/ 0.5 daily 2021-03-01 https://www.ecri-trials.com/studies/master-dapt/steering-committee/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/master-dapt/study-agenda/ 0.5 daily 2019-06-07 https://www.ecri-trials.com/studies/master-dapt/study-design/ 0.5 daily 2017-01-12 https://www.ecri-trials.com/studies/master-dapt/study-news/ 0.5 daily 2019-06-07 https://www.ecri-trials.com/studies/master-dapt/study-purpose/ 0.5 daily 2017-01-12 https://www.ecri-trials.com/studies/optimal/ 0.5 daily 2021-03-15 https://www.ecri-trials.com/studies/optimal/contact/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/optimal/partners/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/optimal/patient-enrolment/ 0.5 daily 2026-04-03 https://www.ecri-trials.com/studies/optimal/study-design/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/optimal/study-news/ 0.5 daily 2022-01-14 https://www.ecri-trials.com/studies/optimal/study-purpose/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/syntax-ii/ 0.5 daily 2021-09-02 https://www.ecri-trials.com/studies/syntax-ii/contact/ 0.5 daily 2021-07-02 https://www.ecri-trials.com/studies/syntax-ii/contemporary-pci/ 0.5 daily 2014-11-05 https://www.ecri-trials.com/studies/syntax-ii/electronic-crf/ 0.5 daily 2015-05-28 https://www.ecri-trials.com/studies/syntax-ii/participating-sites/ 0.5 daily 2014-11-12 https://www.ecri-trials.com/studies/syntax-ii/partners/ 0.5 daily 2014-11-05 https://www.ecri-trials.com/studies/syntax-ii/patient-enrollment-/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/syntax-ii/references/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/syntax-ii/steering-committee/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/syntax-ii/study-agenda/ 0.5 daily 2014-11-12 https://www.ecri-trials.com/studies/syntax-ii/study-design/ 0.5 daily 2014-11-05 https://www.ecri-trials.com/studies/syntax-ii/study-news/ 0.5 daily 2015-01-07 https://www.ecri-trials.com/studies/syntax-ii/study-purpose/ 0.5 daily 2014-11-05 https://www.ecri-trials.com/studies/syntax-ii/syntax-score-ii/ 0.5 daily 2014-11-12 https://www.ecri-trials.com/studies/syntax-iii/ 0.5 daily 2016-05-30 https://www.ecri-trials.com/studies/syntax-iii/contact/ 0.5 daily 2021-02-04 https://www.ecri-trials.com/studies/syntax-iii/investigators/ 0.5 daily 2016-09-08 https://www.ecri-trials.com/studies/syntax-iii/partners/ 0.5 daily 2016-05-03 https://www.ecri-trials.com/studies/syntax-iii/patient-enrolment/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/syntax-iii/steering-committee/ 0.5 daily 2021-02-13 https://www.ecri-trials.com/studies/syntax-iii/study-agenda/ 0.5 daily 2016-05-03 https://www.ecri-trials.com/studies/syntax-iii/study-design/ 0.5 daily 2016-05-03 https://www.ecri-trials.com/studies/syntax-iii/study-news/ 0.5 daily 2016-05-03 https://www.ecri-trials.com/studies/syntax-iii/study-purpose/ 0.5 daily 2016-05-03 https://www.ecri-trials.com/studies/zephyr/ 0.5 daily 2025-09-24 https://www.ecri-trials.com/studies/zephyr/patient-materials/ 0.5 daily 2025-08-28 https://www.ecri-trials.com/studies/zephyr/siv-procedure-manual/ 0.5 daily 2025-11-03 https://www.ecri-trials.com/test/ 0.5 daily 2015-01-08 https://www.ecri-trials.com/test/ 0.5 daily 2015-01-08